Contemporary Management of HIV: New Data From IAC 2016
Source: Contemporary Management of HIV

Slideset

Contemporary Management of HIV: New Data From IAC 2016

In this downloadable slideset, Daniel R. Kuritzkes, MD, and Program Director Eric S. Daar, MD, review key new HIV data presented at the AIDS 2016 meeting.
Format: Microsoft PowerPoint (.ppt)
File size: 607 KB
Date posted: 1/20/2017
  • The Imperative for Women-Initiated HIV Prevention Technologies

    Quarraisha Abdool Karim PhD - 7/8/2016    1 comment / Last Comment: 7/11/2016
    Professor Quarraisha Abdool Karim, PhD, introduces her take on one of the key challenges for women at risk of HIV infection and evolving strategies for prevention. At an upcoming symposium in Durban, Catherine Hankins, MD, PhD, FRCPC, CM, and a multidisciplinary panel of experts will continue this discussion by providing their perspectives on 3 global challenges to treatment and prevention of HIV in women.
  • Switch Strategies in Virologically Suppressed Patients: My Take on New Data From Recent Scientific Meetings

    Anton L. Pozniak MD, FRCP - 1/22/2016    15 comments / Last Comment: 11/14/2016
    Several recent studies have highlighted new approaches to ART switching. Some may expand our options for optimizing long-term virologic suppression in our patients; each should be scrutinized carefully before incorporating into practice.
  • Why ART Trials Specific to Women Are Important

    Kathleen E. Squires MD - 9/28/2016    2 comments / Last Comment: 10/19/2016
    Although almost one half of new HIV infections worldwide occur in women, to date, clinical trials for FDA-approved ART regimens have largely been conducted in men. Here is my take on why women-specific ART trials are important.
  • Selecting First-line Antiretroviral Therapy in Older Patients: New Data, New Options, Key Considerations

    Giovanni Guaraldi MD - 12/16/2015    2 comments / Last Comment: 2/10/2016
    The management of ART in patients aging with HIV requires clinicians to maintain a detailed knowledge of physical and psychological patient health in order to tailor the most appropriate ART regimen.
  • ART in Older Patients: How I Manage Drug–Drug Interactions With Concomitant Medications

    Anton L. Pozniak MD, FRCP - 10/20/2015    16 comments / Last Comment: 5/10/2016
    As our patients age, they experience metabolic changes and more frequently develop conditions such as bone mineral density loss, cardiovascular disease, diabetes, and malignancies, all of which will affect the choice of first-line ART.